Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin α5 expression in U251 glioma cell line

Cancer Research

Volumn 61, Issue 21, 2001, Pages 7985-7991

  Kita, D ^a   Takino, T ^a   Nakada, M ^a   Takahashi, T ^a   Yamashita, J ^a   Sato, H ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR ETS 1; UROKINASE;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION FUNCTION; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; CELL ADHESION; CELL MOVEMENT; CHICK EMBRYO; COLLAGEN TYPE I; DOWN-REGULATION; FIBRONECTINS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLOBINS; HUMANS; INTEGRIN ALPHA5; INTEGRIN BETA3; LIVER NEOPLASMS; PHOSPHORYLATION; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035503443     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ets transcription factors and human disease
2. The Ets family of transcription factors
3. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metal-loproteinase-I and the migratian of vascular endothelial cells
4. Differential regulation of interstitial collagenase (MMP-I) gene expression by ETS transcription factors
5. ETS sites in the promoters of the matrix metalloproteinases collagenase (MMP-I) and stromelysin (MMP-3) are auxiliary elements that regulate basal and phorbol-induced transcription
6. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase I-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
7. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-I promoter via functional interaction of AP-1 and Ets-1 transcription factors
8. An Ets/Spl interaction in the 5′-flanking region of the megakaryocyte-specific α IIb gene appears to stabilize Spl binding and is essential for expression of this TATA-less gene
9. Mouse integrin αv promoter is regulated by transcriptional factors Ets and Spl in melanoma cells
10. The human β 2 integrin CD18 promoter consists of two inverted Ets cis elements
11. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3
12. Cloning and characterization of the human β4-integrin gene promoter and enhancers
13. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription
14. Novel cis-acting elements in the human platelet-derived growth factor B-chain core promoter that mediate gene expression in cultured vascular endothelial cells
15. A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene
16. β1.6-N-acetylglucosamine-bearing N-glycans in human gliomas: Implications for a role in regulating invasivity
17. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated
18. ETS target genes: Identification of egrl as a target by RNA differential display and whole genome PCR techniques
19. Ets-1 positively regulates expression of urokinase-plasminogen activator (uPA) and invasiveness of astrocytic tumors
20. Cancer cell invasion and metastasis
21. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein I (LMPI) induces expression of Ets1 and invasive growth
22. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness
23. Glioblastoma expression of vitronectin and the a vβ3 integrin. Adhesion mechanism for transformed glial cells
24. Control of cell locomotion: Perturbation with an antibody directed against specific glycoproteins
25. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors
26. Experimental metastasis of oncogene-transformed NIH 3T3 cells in chick embryo
27. Integrins and signal transduction pathways: The road taken
28. Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: Clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues
29. Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity
30. Integrins: Versatility, modulation, and signaling in cell adhesion
31. Ligation of integrin α5β3 is required for internalization of vitronectin by integrin αvΒ3
32. Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: Collaborative interactions among integrins
33. The α 5 β 1 fibronectin receptor. Characterization of the α 5 gene promoter
34. Isolation and characterization of a TATA-less promoter for the human β 3 integrin gene
35. Basement membrane invasion of glioma cells mediated by integrin receptors
36. Fibronectin receptor overexpression and loss of transformed phenotype in a stable variant of the K562 cell line
37. Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants
38. Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells
39. Integrin α 5 β 1 expression negatively regulates cell growth: Reversal by attachment to fibronectin
40. Angiogenesis inhibition by transdominant mutant Ets-1
41. The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells
42. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells
43. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness